325715-13-7

Basic information

• Product Name: N-(3-ACETYLPHENYL)-N-METHYLACETAMIDE
• Synonyms: N-(3-ACETYLPHENYL)-N-METHYLACETAMIDE;N-(3-Acetylphenyl)-N-methylacetamide 98%;3(N-Methylacetamido)Acetophenone;N-(3-Acetylphenyl)-N-methylacetamide98%
• CAS NO: 325715-13-7
• Molecular Formula: C₁₁H₁₃NO₂
• Molecular Weight: 191.23
• Mol File: 325715-13-7.mol

Chemical Properties

• Boiling Point: 330.7 °C at 760 mmHg
• Flash Point: 146.3 °C
• Appearance: /
• Density: 1.108 g/cm³
• Vapor Pressure: 0.000163mmHg at 25°C
• Refractive Index: 1.553
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: N-(3-ACETYLPHENYL)-N-METHYLACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-ACETYLPHENYL)-N-METHYLACETAMIDE(325715-13-7)
• EPA Substance Registry System: N-(3-ACETYLPHENYL)-N-METHYLACETAMIDE(325715-13-7)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 325715-13-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
N-(3-acetylphenyl)-N-methylacetamide is used as a potential analgesic and antipyretic agent for its ability to inhibit prostaglandin synthesis, which is associated with pain and fever reduction.
Used in Neurological Conditions Treatment:
In the field of neurology, N-phenacemide is used as a potential treatment for conditions such as epilepsy and migraine headaches, due to its effects on the central nervous system.
However, it is important to note that the use of N-(3-acetylphenyl)-N-methylacetamide is limited due to concerns about its potential toxicity and side effects, which may outweigh its therapeutic benefits in certain applications. Further research and development are necessary to fully understand its safety profile and optimize its use in medical treatments.

InChI:InChI=1/C11H13NO2/c1-8(13)10-5-4-6-11(7-10)12(3)9(2)14/h4-7H,1-3H3

Upstream product

• 7463-31-2 3-Acetamidoacetophenone 
• 77-78-1 dimethyl sulfate 
• 80-48-8 methyl p-toluene sulfonate 
• 99-03-6 1-(3-aminophenyl)ethanone 

Downstream Products

• 1158910-06-5 N-(3-(1-(2-(4-chlorophenoxy)phenylamino)ethyl)phenyl)-N-methylacetamide 
• 1262898-71-4 (E)-4-(3-(N-nethylacetamido)phenyl)-4-oxobut-2-enoic acid 
• 1262898-74-7 (E)-N-methyl-N-(3-(1-((3-methyl-4H-1,2,4-triazol-4-yl)imino)ethyl)phenyl)acetamide 

Relevant articles and documents

TETRAZOLINONE COMPOUND AND USE THEREOF

The compound represented by formula (1): wherein R4 and R5 each represents a hydrogen atom, a halogen atom, or a C1-C3 alkyl group; R6 represents a C1-C4 alkyl group, a C3-C6 cycloalkyl group, or the like; R7, R8, and R9 each represents a hydrogen atom, a halogen atom, or the like; R10 represents a C1-C3 alkyl group, or the like; R13 represents a C1-C3 alkyl group, or the like; and Q represents a phenyl group, or the like; has an excellent control effect on pests.

Salts And Co-Crystals of Pyrazolopyrimidine Compounds, Compositions Thereof And Methods For Their Production And Use

The invention provides pharmaceutically acceptable salts and co-crystals of pyrazolopyrimidine compounds such as zaleplon, indiplon and ocinaplon, processes for their preparation, compositions comprising such salts and co-crystals and methods of using such salts and co-crystals for treating various diseases and conditions.

PRODUCTION OF N-ALKYLAMIDE COMPOUNDS

The present invention provides an efficient process for the production of N-acylaniline derivatives by selectively alkylating an amide group at the nitrogen atom. The process comprises reacting an amide compound of the formula (2): (wherein, R1 and R2 are each independently an alkyl group, a substituted alkyl group, an alkenyl group, a substituted alkenyl group, an aryl group or a substituted aryl group) with a sulfuric acid ester in the presence of a solid metal hydroxide to give an N-alkylamide compound of the formula (3): (wherein R3 is an alkyl group and R1 and R2 have each the same meaning as described above).